CompletedNot Applicable

Virtual Reality at End-of-life

United States9 participantsStarted 2023-10-23

Plain-language summary

The purpose of this research is to determine the effect that repeated, personalized virtual reality experiences have on symptom severity, comparing self-reported symptom severity both pre and post each session, and overtime across sessions. Researchers will also determine if this intervention results in a high rating of presence in VR, and if presence is related to the magnitude of the change in symptoms.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Healthy volunteers are not applicable to this study as they study focuses on pain and symptom management at end-of-life through the virtual reality experience. Inclusion Criteria: * Patients who are hospice care eligible as defined by the Medicare Hospice benefit and receive hospice or palliative care from Hospice and Palliative Care Buffalo. Exclusion Criteria: * Their Palliative Performance Score (PPS) is below 30. * They are not cognitively intact (display symptoms of delirium or senility, or have a cognitive diagnosis such as Alzheimer's or Dementia) as measured by the Confusion Assessment Method (CAM) (Inouye et al., 1990) * They have hearing, vision, or speech impairments that are uncorrected. * They have current symptoms of or a history of dizziness, nausea, headaches, migraines, seizures, or motion sickness. * They do not speak English. * They are not 18 years old.

What they're measuring

Edmonton Symptom Assessment System - Revised (ESAS)

Timeframe: Two weeks

Trial details

NCT IDNCT06149429

SponsorState University of New York at Buffalo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-15

View on ClinicalTrials.gov More End of Life trials